Fidelity Investments’s Global Cord Blood Corporation CO Stock Holding History

Fidelity Investments’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-926	Closed	-$4K	–	5769
2022 Q1	$4K	Buy	+926	New	+$3.85K	﹤0.01%	4538
2015 Q4	–	Sell	-97,900	Closed	-$589K	–	2805
2015 Q3	$589K	Sell	97,900 -9,500	-9%	-$59K	﹤0.01%	2575
2015 Q2	$662K	Sell	107,400 -1,300,365	-92%	-$7.98M	﹤0.01%	2588
2015 Q1	$7.19M	Sell	1,407,765 -250,268	-15%	-$1.23M	﹤0.01%	2121
2014 Q4	$7.5M	Sell	1,658,033 -51,957	-3%	-$247K	﹤0.01%	2100
2014 Q3	$8.36M	Buy	1,709,990 +241,362	+16%	+$1.17M	﹤0.01%	2073
2014 Q2	$8.11M	Buy	1,468,628 +935,828	+176%	+$4.2M	﹤0.01%	2121
2014 Q1	$2.13M	Buy	+532,800	New	+$2.17M	﹤0.01%	2372

Other funds holding CO

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Fidelity Investments's CO Position: Q2 2022 in Review

Fidelity Investments sold out of Global Cord Blood Corporation (CO) in Q2 2022, closing a stake of 926 shares — an estimated $4K sold.

Fidelity Investments first reported a position in CO in Q1 2014 and held it in 8 quarters. The position peaked at $8.36M in Q3 2014. 25 funds tracked by Wall St. Rank hold CO as of Q2 2022.

Fidelity Investments reported no remaining Global Cord Blood Corporation position as of Q2 2022 after selling out during the quarter.
Fidelity Investments sold 926 Global Cord Blood Corporation shares in Q2 2022, an estimated $4K.
Fidelity Investments first reported a position in Global Cord Blood Corporation in Q1 2014 and held it in 8 quarters.
Fidelity Investments's Global Cord Blood Corporation position peaked at $8.36M in Q3 2014.
25 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2022.

Based on Fidelity Investments's 13F filing for Q2 2022, filed 12 Aug 2022.